The Global Vaccine Data Network (GVDN) is the largest ever vaccine safety project involving more than 20 countries and data from more than 250 million people vaccinated against COVID-19.

It aims to investigate and understand rare vaccine side effects such as myocarditis, thrombosis with thrombocytopenia syndrome and Guillain-Barre Syndrome following COVID-19 vaccination which may lead to the prediction, treatment and prevention of side effects.

The following article discusses the importance of globalising vaccine safety research through international collaboration to improve vaccine safety.

To read more, please click on the link below.

Science: Pandemic propels global effort to study rare vaccine side effects